BEST (Bleomycin Electro Sclerotherapy treatment) of Vascular Anomalies

• Research type

  Research Study

• Full title

  A feasibility study based on questionnaire and observation data of Bleomycin electro sclerotherapy treatment of vascular malformations

• IRAS ID

  248206

• Contact name

  Tobian Muir

• Contact email

  tobian.muir@nhs.net

• Clinicaltrials.gov Identifier

  NCT05494710

• Duration of Study in the UK

  1 years, 0 months, 1 days

• Research summary

  The aim of the BEST study is to examine the feasibility of assessing patient and clinician reported outcome of a single electrosclerotherapy treatment of vascular malformations.

  *Sclerotherapy = injection of Bleomycin into vascular birthmarks to seal off abnormal vascular channels

  *Electroporation = application of an electric field to vessels treated with a handheld needle electrode
  *Electrosclerotherapy = a combination of Bleomycin sclerotherapy and electroporation

  The patient feedback and questionnaire forms in this study will be uniquely collected through a smartphone app utilising the Healthcall platform.

• REC name

  North East - Newcastle & North Tyneside 2 Research Ethics Committee

• REC reference

  20/NE/0095

• Date of REC Opinion

  12 Jun 2020

• REC opinion

  Further Information Favourable Opinion